Inhibition of platelet aggregation and antagonism of vasopressin-induced ECG changes in primates by a carboprostacyclin analogue, ZK 36374
- 1 February 1984
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 33 (3) , 333-340
- https://doi.org/10.1016/0049-3848(84)90168-3
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Phamacokinetics and biotransformation of the prostacyclin analogue, ZK 36 374, in the monkey (macaca fascicularis)Prostaglandins, Leukotrienes and Medicine, 1983
- Inhibition of platelet aggregation with intravenous and oral administration of a carboprostacyclin analogue, 15-cyclopentyl-ω-pentanor-5(E)-carbacyclin (ONO 41483) in manProstaglandins, Leukotrienes and Medicine, 1983
- Inhibition of platelet aggegation and reversal of vasopressin-induced ECG changes by a carboprostacyclin analogue, ono 41483, in primatesProstaglandins, Leukotrienes and Medicine, 1982
- Reversal of vasopressin-induced coronary vasoconstriction by a PGE1 analogue (ONO 1206) in primatesProstaglandins, Leukotrienes and Medicine, 1982
- Inhibition of platelet aggregation with intravenous and oral administration of carboprostacyclin in manProstaglandins and Medicine, 1981
- The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374) ? Equipotent to PGI2 in vitroNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1981
- Platelet and other effects of carboprostacyclin - A stable prostacyclin analogueProstaglandins and Medicine, 1980
- Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregationProstaglandins, 1976